17th World ADC London 2027

08th March 2027 - March 11, 2027

The preliminary agenda for the 17th World ADC London is now live, showcasing the latest scientific advances and strategic developments shaping the next generation of antibody-drug conjugates.

Taking place from 8-11 March 2027, the event will unite 700+ ADC leaders to address key challenges across discovery, translational research, clinical development and manufacturing.

With ADC developers focused on overcoming resistance mechanisms, improving therapeutic windows, enhancing linker-payload technologies and advancing novel target selection, the programme will deliver critical insights from 90+ industry experts.

Covering the full development pathway, attendees will gain access to emerging data, case studies and practical strategies designed to accelerate the development of safer, more effective ADC therapies.

View the preliminary agenda to explore the science driving the future of ADC innovation.

More Info